Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Translesional pressure measurements to see whether a mesenteric artery narrowing causes symptoms.

Official title: Translesional PRESSURE Measurements to Assess Clinical Relevance of a Mesenteric Artery Stenosis (PRESSURE-study)

Run by Erasmus Medical Center · NCT07059520 · Data updated 2026-11-12

This study will test whether measuring the pressure across a narrowed mesenteric artery helps identify which adults with chronic mesenteric ischemia who are scheduled for endovascular treatment will benefit from treatment.

More Acute Mesenteric Ischemia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment125 (estimated)
SponsorErasmus Medical Center
Academic / other
Locations3 sites (Enschede, Overijssel and 2 other locations)
StatusRecruiting
StartedApril 1, 2025
Main results expectedJuly 1, 2027
Study endsJanuary 1, 2028
Registry record updatedJuly 31, 2025
Trial IDNCT07059520 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with chronic mesenteric ischemia who are scheduled for an endovascular procedure of the mesenteric arteries and can give informed consent are the intended participants.

Probably not a fit

Patients with acute mesenteric ischemia, normal vascular anatomy variants (common origin of SMA and CA), those unable to consent, pregnant people, or those not undergoing endovascular treatment are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, multicenter study in which pressure measurements (Pd/Pa or similar translesional metrics) are taken across mesenteric artery stenoses during planned endovascular procedures. Investigators will compare these hemodynamic measurements with imaging, clinical history, and functional test findings and will follow patient-reported symptom relief after revascularization. The goal is to determine whether pressure-guided information better predicts symptomatic improvement than imaging alone. The study includes adult patients with chronic mesenteric ischemia undergoing endovascular management at participating Dutch centers.

Why it matters

Potential benefit: If successful, this approach could help avoid unnecessary procedures and improve the chance that patients treated for mesenteric artery narrowing actually experience symptom relief.

How similar studies have gone: Pressure-based (Pd/Pa/FFR-like) methods have been successful and widely adopted in coronary disease and have some supportive retrospective data in mesenteric disease, but prospective validation for mesenteric stenoses is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients with chronic mesenteric ischemia (CMI) and scheduled for endovascular procedure of the mesenteric arteries
* Age ≥18 years of age
* Patients who gave informed consent

Exclusion Criteria:

* Patients presenting with acute mesenteric ischemia
* Common origin of the SMA and CA (normal variant)
* Patients unable to give informed consent
* Pregnancy
* Other criteria the physician considers not compatible with this study

Where it's running

  • Erasmus University Medical Centre Rotterdam
    Rotterdam, South Holland, Netherlands
    Recruiting
  • Franciscus
    Rotterdam, South Holland, Netherlands
    Recruiting
  • Medisch Spectrum Twente
    Enschede, Overijssel, Netherlands
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Measuring a biomarker in patients with chronic mesenteric ischemia

    This study is testing if measuring a specific protein in the blood can help doctors better understand and treat patients with chronic mesenteric ischemia and related conditions.

    Recruiting Oslo University Hospital · Oslo, Oslo · NCT06468774

  • Helping find chronic mesenteric ischemia earlier

    This project tests whether a 13C-butyrate breath test combined with CT-based mesenteric artery calcium scoring can help diagnose adults with suspected chronic mesenteric ischemia.

    Recruiting at 2 sites Erasmus Medical Center · Enschede, Overijssel and 3 other locations · NCT05735002

  • Predictors of transmural NOMI in ICU patients with suspected acute mesenteric ischemia

    This study looks at ICU patients with suspected acute mesenteric ischemia to see which factors best predict transmural non-occlusive mesenteric ischemia.

    Recruiting at 2 sites University of Tartu · Tallinn, Tallinn and 1 other locations · NCT07610356

  • Life after acute mesenteric ischemia

    See how adults treated for acute mesenteric ischemia at Strasbourg University Hospitals between 2010 and 2022 are doing in terms of quality of life.

    Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07303153

  • Blood markers to help diagnose acute mesenteric ischemia

    We will test whether measuring adenosine deaminase in blood helps doctors quickly diagnose acute mesenteric ischemia in adults who come to hospital with severe unexplained abdominal pain.

    Recruiting Assistance Publique Hopitaux De Marseille · Marseille · NCT06869564

  • Oral antibiotics for treating acute mesenteric ischemia

    This study is testing if giving oral antibiotics to patients with acute mesenteric ischemia can help them survive better and avoid surgery.

    Recruiting at 2 sites Phase 3 Assistance Publique - Hôpitaux de Paris · Clichy, France and 3 other locations · NCT06387147

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.